Page last updated: 2024-11-12

kdo2-lipid a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Kdo2-lipid A: a complex lipopolysaccharide known to activate toll-like 4 receptors on mammalian cells.structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11355423
CHEBI ID27963
MeSH IDM0492902

Synonyms (18)

Synonym
alpha-kdo-(2->4)-alpha-kdo-(2->6)-lipid a
dodecanoyl-(tetradecanoyl)-kdo2-lipid iv(a)
C06026 ,
di[3-deoxy-d-manno-octulosonyl]-lipid a
kdo2-lipid a
3-deoxy-alpha-d-manno-oct-2-ulopyranonosyl-(2->4)-3-deoxy-alpha-d-manno-oct-2-ulopyranonosyl-(2->6)-2-deoxy-2-[(3r)-3-(dodecanoyloxy)tetradecanamido]-4-o-phosphono-3-o-[(3r)-3-(tetradecanoyloxy)tetradecanoyl]-beta-d-glucopyranosyl-(1->6)-2-deoxy-3-o-[(3r)
CHEBI:27963
kdo2-lipid (a)
(kdo)2-lipid a
Q27103425
(2~{r},4~{r},5~{r},6~{r})-6-[(1~{r})-1,2-bis(oxidanyl)ethyl]-2-[(2~{r},4~{r},5~{r},6~{r})-6-[(1~{r})-1,2-bis(oxidanyl)ethyl]-2-carboxy-2-[[(2~{r},3~{s},4~{r},5~{r},6~{r})-5-[[(3~{r})-3-dodecanoyloxytetradecanoyl]amino]-6-[[(2~{r},3~{s},4~{r},5~{r},6~{r})-
123621-04-5
DTXSID301318089
kdo(2)-lipid (a) (bacteria)
CS-0185592
123621-04-5 (free base)
(3-deoxy-d-manno-octulosonic acid)2-lipid a
HY-W127355
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
lipid AsGlycophospholipids that are the components of endotoxins held responsible for the toxicity of Gram-negative bacteria. Lipid A is the innermost of the three regions of the lipopolysaccharide (LPS) molecule, and its hydrophobic nature allows it to anchor the LPS to the outer membrane. Four acyl chains attached directly to two (1->6)-linked glucosamine sugars are beta-hydroxy acyl chains usually between 10 and 16 carbons in length. Two additional acyl chains are often attached to the beta-hydroxy group.
dodecanoate esterAny fatty acid ester in which the carboxylic acid component is lauric acid.
tetradecanoate esterA fatty acid ester obtained by condensation of the carboxy group of tetradecanoic acid (also known as myristic acid) with a hydroxy group of an alcohol or phenol.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (35)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (22.86)29.6817
2010's26 (74.29)24.3611
2020's1 (2.86)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.73 (24.57)
Research Supply Index3.58 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index28.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (17.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other29 (82.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]